Clinical Trials Logo

Breast Neoplasms clinical trials

View clinical trials related to Breast Neoplasms.

Filter by:

NCT ID: NCT02349217 Completed - Breast Cancer Clinical Trials

Mindfulness Based Couples Therapy

Start date: January 23, 2015
Phase: N/A
Study type: Interventional

The goal of this study is to explore the effects of a Mindfulness Based Couples Intervention on relationship satisfaction with quality of life and immune system function among breast cancer survivors and their partners.

NCT ID: NCT02348684 Completed - Clinical trials for Node Positive Breast Cancer

Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation

Start date: March 2012
Phase:
Study type: Observational

The association between radiation exposure and cardiac disease is well recognized, it is not fully understood if there exists an optimal or "safe" radiation dose-volume relationship.

NCT ID: NCT02348320 Completed - Clinical trials for Triple Negative Breast Cancer

Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy

Start date: June 17, 2015
Phase: Phase 1
Study type: Interventional

This is a phase 1 open-label study to evaluate the safety and immunogenicity of a personalized polyepitope DNA vaccine strategy. The personalized polyepitope DNA vaccines will be formulated as naked plasmid DNA vaccines. The hypothesis of this study is that personalized polyepitope DNA vaccines will be safe for human administration and capable of generating measurable CD8 T cell responses to mutant tumor-specific antigens.

NCT ID: NCT02347449 Completed - Clinical trials for Hormone Receptor Positive Malignant Neoplasm of Breast

The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

Start date: October 2014
Phase: N/A
Study type: Interventional

The main goal of this study is to characterize whether the results of the Oncotype DX® assay affect the physician's treatment recommendations for the adjuvant treatment of women with ER-positive (ER+), early breast cancer (EBC) with 1-3 positive lymph nodes who are potential candidates for chemotherapy, but for whom the benefits of chemotherapy may be uncertain.

NCT ID: NCT02344940 Completed - Breast Cancer Clinical Trials

Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer

TTOS
Start date: December 2014
Phase: Phase 4
Study type: Interventional

To compare the safety of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer by monitoring gynecological abnormality,blood lipid level,hepatic abnormality,estrogen level and perimenopausal symptoms.

NCT ID: NCT02344550 Completed - Clinical trials for Metastatic Breast Cancer

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer

LEO
Start date: January 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of addition of everolimus to letrozole with LHRH agonist in premenopausal metastatic breast cancer patients who failed to tamoxifen treatment.

NCT ID: NCT02341820 Completed - Breast Neoplasms Clinical Trials

PICTURE Breast L: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Longitudinal

PICTURE L
Start date: April 2014
Phase: N/A
Study type: Observational

This project which is fully funded by the European Union FP7 Program is designed to pull together all the information we obtain from scans and x-rays to design a personalised 3-D digital model of each patient, their anatomy and disease. We can then use this as follows: as (i) an aid to surgical planning to enable objective clinical decision making (ii) a decision support tool to communicate the available treatment options to the patient and facilitate shared decision making and provision of personalised care and (iii) to enable standardised objective evaluation of the aesthetic outcome of the treatment procedures. This study aims to demonstrate the ability of the Virtual Physiological Human concept to empower breast cancer patients and assess the impact on their care and quality of life.

NCT ID: NCT02340858 Completed - Breast Cancer Clinical Trials

Percutaneous Irreversible Electroportion for Unresectable Breast Cancer

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

This trial is studying how well Irreversible Electroportion (IRE) therapy works in treating patients with breast cancer. IRE kills tumor cells by Electrical impulses creating nano-pore on the cell membrane and inducing target cell death.This may be an effective treatment for patients with unresectable breast cancer.

NCT ID: NCT02338804 Completed - Breast Neoplasms Clinical Trials

Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient

Start date: January 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safeness and effectiveness of mix vaccine (MV). Enrolled patients will receive standard treatment according to National Comprehensive Cancer Network (NCCN) guide line with or without combining MV injection. The efficacy and side effect will be compared between the two groups.

NCT ID: NCT02338349 Completed - Clinical trials for Advanced ER+, HER2-Negative Breast Cancer

A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer

Start date: January 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and preliminary efficacy of elacestrant (RAD1901) in patients with advanced ER+, HER2-negative breast cancer.